Business Context and Reporting Period
Company: NeOnc Technologies Holdings, Inc. (NTHI)
Filing Type: Form 8-K (Current Report)
Date of Report: July 24, 2025
Reporting Period: Event date July 24, 2025; Signed July 30, 2025
Context: The Company entered into a binding Letter of Intent (LOI) to acquire equity interests in a newly formed Delaware LLC from Dr. Ishwar Puri and Beth Levinson. This transaction involves the acquisition of specific intellectual property and the appointment of Dr. Puri to the Board of Directors.
Key Financial Metrics
Note: This filing is a Current Report regarding a material agreement and does not contain audited financial statements, revenue, profit, or cash flow data for a reporting period.
- Transaction Consideration: Approximately 120,000 shares of Company common stock (attributed value of $25.00 per share), subject to reduction for transaction fees.
- Patent Acquisition Cost: $500,000 in cash for US Patent No. 11,788,057 B2 from McMaster University.
- Financing Mechanism: The Company will issue a $500,000 promissory note to the LLC to fund the patent purchase, which will be forgiven upon closing of the Proposed Transaction.
- Debt/Liquidity Impact: The filing does not provide current debt levels, liquidity ratios, or cash balances.
Material Changes
This filing reports a material definitive agreement rather than a change in historical financial performance. Key changes include:
- Asset Acquisition: Planned acquisition of US Patent No. 11,788,057 B2 via a newly formed LLC.
- Capital Structure: Anticipated issuance of up to 120,000 shares of common stock to the Holders.
- Corporate Governance: Dr. Ishwar K. Puri will be appointed to the Company's Board of Directors upon closing.
Guidance, Outlook, and Risks
Outlook and Conditions: The Proposed Transaction is subject to several conditions, including the formation of the LLC, completion of due diligence by the Company, and the execution of a Patent Transfer Agreement between the LLC and McMaster University.
Risks and Contingencies:
- Closing Risk: The transaction is not final and depends on the successful execution of the Patent Transfer Agreement and due diligence.
- Fee Adjustment: The final number of shares issued will be reduced by an amount equal to aggregate transaction fees divided by $25.00.
- Valuation Assumption: The share consideration is based on an attributed value of $25.00 per share, which may differ from the market price at the time of closing.
Investor Verification Checklist
- Verify the final share count issued after deducting transaction fees.
- Confirm the successful execution of the Patent Transfer Agreement with McMaster University.
- Review the full text of the Letter of Intent (Exhibit 10.1) for additional covenants or termination rights.
- Monitor the Company's cash position to ensure it can fund the $500,000 promissory note prior to forgiveness.
- Check for any subsequent filings regarding the completion of due diligence or the appointment of Dr. Puri to the Board.